Back

The Impact of 6-Month ART Dispensing (6MMD) on Retention in Malawi's HIV Program: A Target Trial Emulation Study

2026-02-17 hiv aids Title + abstract only
View on medRxiv
Show abstract

BackgroundSix multi-month dispensing (6MMD) of antiretroviral therapy (ART) for HIV treatment clients has expanded rapidly in the past decade, but its effect on individual outcomes in routine (non-trial) care is still poorly documented and based on observational programmatic data. Malawi launched 6MMD in April 2019 and scaled-up implementation in 2020. We compared retention in care for clients who received 6MMD to those who did not using a target trial emulation (TTE) approach to minimize bias. ...

Predicted journal destinations